BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 31121178)

  • 1. IL-33-Induced Atopic Dermatitis-Like Inflammation in Mice Is Mediated by Group 2 Innate Lymphoid Cells in Concert with Basophils.
    Imai Y; Yasuda K; Nagai M; Kusakabe M; Kubo M; Nakanishi K; Yamanishi K
    J Invest Dermatol; 2019 Oct; 139(10):2185-2194.e3. PubMed ID: 31121178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basophils promote innate lymphoid cell responses in inflamed skin.
    Kim BS; Wang K; Siracusa MC; Saenz SA; Brestoff JR; Monticelli LA; Noti M; Tait Wojno ED; Fung TC; Kubo M; Artis D
    J Immunol; 2014 Oct; 193(7):3717-25. PubMed ID: 25156365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-33 in atopic dermatitis.
    Imai Y
    J Dermatol Sci; 2019 Oct; 96(1):2-7. PubMed ID: 31455506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous atopic dermatitis in mice with a defective skin barrier is independent of ILC2 and mediated by IL-1β.
    Schwartz C; Moran T; Saunders SP; Kaszlikowska A; Floudas A; Bom J; Nunez G; Iwakura Y; O'Neill L; Irvine AD; McKenzie ANJ; Ogg G; Walsh PT; Demengeot J; Fallon PG
    Allergy; 2019 Oct; 74(10):1920-1933. PubMed ID: 30937919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased frequencies of basophils, type 2 innate lymphoid cells and Th2 cells in skin of patients with atopic dermatitis but not psoriasis.
    Mashiko S; Mehta H; Bissonnette R; Sarfati M
    J Dermatol Sci; 2017 Nov; 88(2):167-174. PubMed ID: 28743611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice.
    Imai Y; Yasuda K; Sakaguchi Y; Haneda T; Mizutani H; Yoshimoto T; Nakanishi K; Yamanishi K
    Proc Natl Acad Sci U S A; 2013 Aug; 110(34):13921-6. PubMed ID: 23918359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-17A-Producing Innate Lymphoid Cells Promote Skin Inflammation by Inducing IL-33-Driven Type 2 Immune Responses.
    Kim MH; Jin SP; Jang S; Choi JY; Chung DH; Lee DH; Kim KH; Kim HY
    J Invest Dermatol; 2020 Apr; 140(4):827-837.e9. PubMed ID: 31628929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ILC2s and Basophils Team Up to Orchestrate IL-33-Induced Atopic Dermatitis.
    Ryffel B; Alves-Filho JC
    J Invest Dermatol; 2019 Oct; 139(10):2077-2079. PubMed ID: 31543211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis.
    Salimi M; Barlow JL; Saunders SP; Xue L; Gutowska-Owsiak D; Wang X; Huang LC; Johnson D; Scanlon ST; McKenzie AN; Fallon PG; Ogg GS
    J Exp Med; 2013 Dec; 210(13):2939-50. PubMed ID: 24323357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Proinflammatory Role of Type 2 Innate Lymphoid Cells in Murine Immune-Mediated Hepatitis.
    Neumann K; Karimi K; Meiners J; Voetlause R; Steinmann S; Dammermann W; Lüth S; Asghari F; Wegscheid C; Horst AK; Tiegs G
    J Immunol; 2017 Jan; 198(1):128-137. PubMed ID: 27872212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory syncytial virus prevents the subsequent development of ovalbumin-induced allergic responses by inhibiting ILC2 via the IL-33/ST2 pathway.
    Wang D; Bai S; Cui Y; Zhao N; Qi F; Liu J; Zeng S; Xu L; Hu H; Liu B
    Immunotherapy; 2018 Sep; 10(12):1065-1076. PubMed ID: 30027786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor 2 ligands promote chronic atopic dermatitis through IL-4-mediated suppression of IL-10.
    Kaesler S; Volz T; Skabytska Y; Köberle M; Hein U; Chen KM; Guenova E; Wölbing F; Röcken M; Biedermann T
    J Allergy Clin Immunol; 2014 Jul; 134(1):92-9. PubMed ID: 24698321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-33-induced keratoconjunctivitis is mediated by group 2 innate lymphoid cells in mice.
    Hosotani Y; Yasuda K; Nagai M; Yamanishi K; Kanazawa N; Gomi F; Imai Y
    Allergol Int; 2023 Apr; 72(2):324-331. PubMed ID: 37010996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-bet inhibits innate lymphoid cell-mediated eosinophilic airway inflammation by suppressing IL-9 production.
    Matsuki A; Takatori H; Makita S; Yokota M; Tamachi T; Suto A; Suzuki K; Hirose K; Nakajima H
    J Allergy Clin Immunol; 2017 Apr; 139(4):1355-1367.e6. PubMed ID: 27670243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-37 Targets TSLP-Primed Basophils to Alleviate Atopic Dermatitis.
    Hou T; Tsang MS; Kan LL; Li P; Chu IM; Lam CW; Wong CK
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Group 2 Innate Lymphoid Cells (ILC2s) Are Key Mediators of the Inflammatory Response in Polymicrobial Sepsis.
    Chun TT; Chung CS; Fallon EA; Hutchins NA; Clarke E; Rossi AL; Cioffi WG; Heffernan DS; Ayala A
    Am J Pathol; 2018 Sep; 188(9):2097-2108. PubMed ID: 29935165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cysteinyl leukotriene E
    Salimi M; Stöger L; Liu W; Go S; Pavord I; Klenerman P; Ogg G; Xue L
    J Allergy Clin Immunol; 2017 Oct; 140(4):1090-1100.e11. PubMed ID: 28115217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant Expression of Bacterial Pattern Recognition Receptor NOD2 of Basophils and Microbicidal Peptides in Atopic Dermatitis.
    Wong CK; Chu IM; Hon KL; Tsang MS; Lam CW
    Molecules; 2016 Apr; 21(4):471. PubMed ID: 27077833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of group 2 innate lymphoid cells exacerbates and confers corticosteroid resistance to mouse nasal type 2 inflammation.
    Morikawa T; Fukuoka A; Matsushita K; Yasuda K; Iwasaki N; Akasaki S; Fujieda S; Yoshimoto T
    Int Immunol; 2017 May; 29(5):221-233. PubMed ID: 28541554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukotriene C4 Potentiates IL-33-Induced Group 2 Innate Lymphoid Cell Activation and Lung Inflammation.
    Lund SJ; Portillo A; Cavagnero K; Baum RE; Naji LH; Badrani JH; Mehta A; Croft M; Broide DH; Doherty TA
    J Immunol; 2017 Aug; 199(3):1096-1104. PubMed ID: 28667163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.